| 000 | 01740 a2200517 4500 | ||
|---|---|---|---|
| 005 | 20250512163051.0 | ||
| 264 | 0 | _c19701209 | |
| 008 | 197012s 0 0 eng d | ||
| 022 | _a0014-2999 | ||
| 024 | 7 |
_a10.1016/0014-2999(70)90065-8 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aVaragić, V M | |
| 245 | 0 | 0 |
_aThe glycogenolytic and hypertensive effect of physostigmine in the anti-nerve-growth-factor-serum-treated rats. _h[electronic resource] |
| 260 |
_bEuropean journal of pharmacology _cOct 1970 |
||
| 300 |
_a194-202 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article | ||
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aBlood Pressure _xdrug effects |
| 650 | 0 | 4 | _aBrain Chemistry |
| 650 | 0 | 4 |
_aCerebellum _xanalysis |
| 650 | 0 | 4 |
_aCerebral Cortex _xanalysis |
| 650 | 0 | 4 |
_aDiaphragm _xdrug effects |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 |
_aGanglia, Autonomic _xdrug effects |
| 650 | 0 | 4 |
_aGlycogen _xanalysis |
| 650 | 0 | 4 | _aGrowth Inhibitors |
| 650 | 0 | 4 |
_aHypothalamus _xanalysis |
| 650 | 0 | 4 |
_aLiver _xdrug effects |
| 650 | 0 | 4 |
_aLiver Glycogen _xanalysis |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 |
_aMedulla Oblongata _xanalysis |
| 650 | 0 | 4 |
_aMesencephalon _xdrug effects |
| 650 | 0 | 4 |
_aMyocardium _xanalysis |
| 650 | 0 | 4 |
_aNerve Growth Factors _xantagonists & inhibitors |
| 650 | 0 | 4 |
_aNerve Tissue _xdrug effects |
| 650 | 0 | 4 |
_aNeurons _xdrug effects |
| 650 | 0 | 4 | _aOrgan Size |
| 650 | 0 | 4 |
_aPhysostigmine _xpharmacology |
| 650 | 0 | 4 | _aRats |
| 700 | 1 | _aMrsulja, B B | |
| 700 | 1 | _aStosić, N | |
| 700 | 1 | _aPasić, M | |
| 700 | 1 | _aTerzić, M | |
| 773 | 0 |
_tEuropean journal of pharmacology _gvol. 12 _gno. 2 _gp. 194-202 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/0014-2999(70)90065-8 _zAvailable from publisher's website |
| 999 |
_c5474065 _d5474065 |
||